Experimental investigations with anti-cancer drugs for carcinogenicity with special reference to immunedepression.
D015081:2-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives; D000477:Alkylating Agents / Q000633:toxicity*; D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D002273:Carcinogens; D003043:Cocarcinogenesis; D003520:Cyclophosphamide / Q000633:toxicity; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D009369:Neoplasms / Q000139:chemically induced; D009374:Neoplasms, Experimental / Q000139:chemically induced* / Q000276:immunology; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects; D051381:Rats
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D002273:Carcinogens; D009588:Nitrogen Mustard Compounds; D003520:Cyclophosphamide; D015081:2-Naphthylamine